Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recombinant activated factor VII and epsilon aminocaproic acid treatment of a patient with Glanzmann's thrombasthenia for nasal polipectomy.

× No keyword cloud information.

6 in total

1. Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia.

Authors: M C Poon; C Demers; F Jobin; J W Wu
Journal: Blood Date: 1999-12-01 Impact factor: 22.113

2. [Thrombasthenia of Glanzmann. Vaginal hysterectomy treated with recombinant factor VIIa].

Authors: João S Mairos; Ana C Bernardo; Anabela R Neves; Ana P Campos; Filomena P Nunes; João S Saraiva; Maria C Trinidade; Alcides H Pereira; Ana Marques Pereira; Carlos B Falcão; Hélio Retto
Journal: Acta Med Port Date: 2004-04-30

Review 3. Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents.

Authors: Man-Chiu Poon; Rainer Zotz; Giovanni Di Minno; Zvika S Abrams; Jens B Knudsen; Yves Laurian
Journal: Semin Hematol Date: 2006-01 Impact factor: 3.851

4. Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. International Registry on Recombinant Factor VIIa and Congenital Platelet Disorders Group.

Authors: M C Poon; R d'Oiron
Journal: Blood Coagul Fibrinolysis Date: 2000-04 Impact factor: 1.276

5. Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with Glanzmann thrombasthenia.

Authors: B T Yilmaz; B Alioglu; E Ozyurek; H T Akay; S Mercan; N Ozbek
Journal: Pediatr Cardiol Date: 2005 Nov-Dec Impact factor: 1.655

Review 6. Molecular basis of Glanzmann's Thrombasthenia and current strategies in treatment.

Authors: S Bellucci; J Caen
Journal: Blood Rev Date: 2002-09 Impact factor: 8.250

6 in total